DE60309447D1 - Verfahren zur verabreichung von injizierbarem antibiotikum im ohr eines tieres - Google Patents

Verfahren zur verabreichung von injizierbarem antibiotikum im ohr eines tieres

Info

Publication number
DE60309447D1
DE60309447D1 DE60309447T DE60309447T DE60309447D1 DE 60309447 D1 DE60309447 D1 DE 60309447D1 DE 60309447 T DE60309447 T DE 60309447T DE 60309447 T DE60309447 T DE 60309447T DE 60309447 D1 DE60309447 D1 DE 60309447D1
Authority
DE
Germany
Prior art keywords
animal
ear
administration
injectable antibiotics
injectable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60309447T
Other languages
English (en)
Other versions
DE60309447T2 (de
DE60309447T3 (de
Inventor
A Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co LLC
Original Assignee
Pharmacia and Upjohn Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28454766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60309447(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia and Upjohn Co LLC filed Critical Pharmacia and Upjohn Co LLC
Application granted granted Critical
Publication of DE60309447D1 publication Critical patent/DE60309447D1/de
Publication of DE60309447T2 publication Critical patent/DE60309447T2/de
Publication of DE60309447T3 publication Critical patent/DE60309447T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60309447.3T 2002-03-21 2003-03-19 Verfahren zur verabreichung von injizierbarem antibiotikum in dem ohr eines tieres Expired - Lifetime DE60309447T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36621202P 2002-03-21 2002-03-21
US366212P 2002-03-21
EP03723787.2A EP1485040B2 (de) 2002-03-21 2003-03-19 Verfahren zur verabreichung von injizierbarem antibiotikum in dem ohr eines tieres
PCT/US2003/008571 WO2003079923A1 (en) 2002-03-21 2003-03-19 Method of administering an injectable antibiotic to the ear of an animal

Publications (3)

Publication Number Publication Date
DE60309447D1 true DE60309447D1 (de) 2006-12-14
DE60309447T2 DE60309447T2 (de) 2007-03-29
DE60309447T3 DE60309447T3 (de) 2020-04-23

Family

ID=28454766

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309447.3T Expired - Lifetime DE60309447T3 (de) 2002-03-21 2003-03-19 Verfahren zur verabreichung von injizierbarem antibiotikum in dem ohr eines tieres

Country Status (15)

Country Link
US (3) US20030181398A1 (de)
EP (1) EP1485040B2 (de)
JP (1) JP4365222B2 (de)
KR (1) KR20040097187A (de)
CN (1) CN1635856A (de)
AT (1) ATE343980T1 (de)
AU (1) AU2003230697B2 (de)
BR (1) BR0308523A (de)
CA (1) CA2476327A1 (de)
DE (1) DE60309447T3 (de)
ES (1) ES2275092T5 (de)
IL (1) IL164158A0 (de)
MX (1) MXPA04009177A (de)
WO (1) WO2003079923A1 (de)
ZA (1) ZA200406501B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107982214B (zh) * 2016-10-26 2021-02-05 华中农业大学 兽用恩诺沙星固体脂质纳米混悬液及其制备方法
BR112019013016B1 (pt) 2016-12-23 2023-05-02 Intervet International B.V. Compostos antibacterianos, composição farmacêutica que os compreende e uso dos referidos compostos
MX2019007350A (es) 2016-12-23 2019-11-05 Intervet Int Bv Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
CN107802613B (zh) * 2017-11-13 2020-01-31 郑州大学 一种掩味肠道速释型替米考星微纳米干混悬剂及其制备方法
AU2019296380B2 (en) 2018-06-25 2024-02-29 Intervet International B.V. Compounds for the treatment of bovine or swine respiratory disease
US20210292284A1 (en) * 2018-06-25 2021-09-23 Intervet Inc. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni
CN109077999A (zh) * 2018-08-31 2018-12-25 田红卫 一种长效缓释替米考星注射液及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2883984A (en) * 1957-09-09 1959-04-28 Pfizer & Co C Pellet implanter
US2999020A (en) * 1959-06-09 1961-09-05 Hodges Res & Dev Co Processes for the tendering of meat
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
DE3869135D1 (de) * 1987-07-29 1992-04-16 Upjohn Co Kontrollierte freisetzung von antibiotika-salzen aus einem implantat.
ZA889601B (en) * 1987-09-23 1989-10-25 Petrus Burger Andries A composition for use in treating animals
US5258528A (en) * 1990-11-30 1993-11-02 Warner-Lambert Company Individual stereoisomers of pyrrolidine methanamines substituted on the ring nitrogen by a 1-phenylethyl group
AU694419B2 (en) † 1993-03-12 1998-07-23 Zoetis P&U Llc Crystalline ceftiofur free acid
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal

Also Published As

Publication number Publication date
US20030181398A1 (en) 2003-09-25
US8968759B2 (en) 2015-03-03
ES2275092T5 (es) 2020-06-17
ES2275092T3 (es) 2007-06-01
US20110098266A1 (en) 2011-04-28
KR20040097187A (ko) 2004-11-17
CA2476327A1 (en) 2003-10-02
JP2005520624A (ja) 2005-07-14
EP1485040A1 (de) 2004-12-15
ATE343980T1 (de) 2006-11-15
ZA200406501B (en) 2005-06-21
IL164158A0 (en) 2005-12-18
EP1485040B1 (de) 2006-11-02
AU2003230697A1 (en) 2003-10-08
EP1485040B2 (de) 2019-12-11
DE60309447T2 (de) 2007-03-29
DE60309447T3 (de) 2020-04-23
MXPA04009177A (es) 2004-12-07
AU2003230697B2 (en) 2008-07-17
CN1635856A (zh) 2005-07-06
JP4365222B2 (ja) 2009-11-18
BR0308523A (pt) 2005-02-01
WO2003079923A1 (en) 2003-10-02
US20150182454A1 (en) 2015-07-02

Similar Documents

Publication Publication Date Title
DK1758629T3 (da) Nål- og muffeenhed til en automatisk injektor
HK1095266A1 (en) Controlled release sterile injectable aripiprazole formulation and method
WO2006050279A3 (en) System and method to reduce discomfort using nerve stimulation
DE602007006419D1 (de) Verfahren zur verwendung von guava-extrakt und zusammensetzung mit guava-extrakt
AU2014235466A8 (en) Dental devices and systems and methods for making the same
SE0301676D0 (sv) Elastomerbildande barriär-preparat
ATE341550T1 (de) Quinolinyl-pyrrolopyrazole
DE60309447D1 (de) Verfahren zur verabreichung von injizierbarem antibiotikum im ohr eines tieres
WO2004032849A3 (en) Methods of administering fgf18
WO2005009287A3 (en) Drug delivery to the inner ear and methods of using same
DE602006019754D1 (de) Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden
WO2003092629A3 (en) Methods of simultaneously treating mucositis and fungal infection
BR0312099A (pt) Uso de toxina bolutìnica, bem como composição farmacêutica
DE60336984D1 (de) Verfahren zur Definition einer Gruppe zwischen bidirektionalen Objekten
DE60226517D1 (de) Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme
RU2007143493A (ru) Способ эндолимфатического введения антибиотиков при лечении больных шейным лимфаденитом
AU2003272387A1 (en) System and method for well workover with horizontal tree
EA200600070A1 (ru) Инъецируемая галеновая форма флупиртина
CA2381095A1 (en) Method for treating insulin resistance through hepatic nitric oxide
DE60303149D1 (de) Salz von morphin-6-glucuronid
UA67629A (en) Method for correcting stress component in experimental model of peritonitis
UA67630A (en) Method for correcting stress component in experimental model of acute adnexitis
RU2002133845A (ru) Способ моделирования сенсоневральной тугоухости
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
ATE466579T1 (de) Verfahren zur herstellung von benzimidazolen

Legal Events

Date Code Title Description
8363 Opposition against the patent